Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Trading Statement

15 Jan 2014 07:00

RNS Number : 6625X
Plant Health Care PLC
15 January 2014
 

 

15 January 2014

 

 

 

 

Plant Health Care plc

 

("Plant Health Care" or "the Company")

 

Trading Update

 

 

Plant Health Care plc, ("PHC"), a leading provider of novel patent-protected biological products to the global agriculture markets, provides the following update for the 12 months to 31 December 2013 ahead of its full year results announcement on 24 March 2014.

 

Trading continues to be in line with the Board's expectations. The full year results will reflect the implementation of the new strategy that was announced following the US$20 million fundraising completed in April 2013.

 

In September's interim results statement, PHC reported significant progress, most notably:

 

· New management in place in new headquarters in Raleigh, North Carolina

· New Development and Commercial agreements with Arysta LifeScience and others

· Moved to expanded research facilities in Seattle which enhanced and accelerated investment in the discovery and evaluation of a new generation of Harpin products

 

In the second half of the year, implementation of the new strategy has continued:

 

· In July, the Company's agreement with Monsanto was discontinued and PHC recovered its globally licensed rights to Harpin as a seed treatment.

· In September, Jeff Hovey was appointed Chief Financial Officer. Since joining, he has completed the transfer of the Company's administration and accounting functions from Pittsburgh to Raleigh. The Pittsburgh office was closed on 31 December 2013.

· In November, PHC completed the sale of its non-core European distribution activities while retaining a core capability in the UK and Spain to enable the continued exploitation of Europe, South Africa and certain other non-American markets.

 

All of these actions have been achieved in line with the targets set out at the time of the fundraising.

 

The full year results will reflect these changes and will set out the contribution from our continuing activities and those relating to discontinued and non-core activities.

 

~ ENDS ~

 

For further information, please contact:

 

Plant Health Care plc

Paul Schmidt, Chief Executive Officer

Tel: +1 919 926 1600

Liberum Capital - Nomad and Broker

Clayton Bush / Thomas Bective

Tel: +44 (0) 20 3100 2222

Powerscourt

Sophie Moate / Nick Dibden

Tel: +44 (0) 20 7250 1446

 

About Plant Health Care plc: Plant Health Care is a leading provider of patent protected biological products aimed at the agriculture industry that are environmentally beneficial. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management.

 

Further information is available at: www.planthealthcare.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSALLISLIS
Date   Source Headline
14th Sep 20157:00 amRNSHalf Yearly Report
19th Aug 20157:00 amRNSBlocklisting Interim Review
13th Jul 20157:00 amRNSPHC Granted Product Registration in Brazil
18th Jun 20157:00 amRNSDirector/PDMR Shareholding
17th Jun 20152:20 pmRNSResult of AGM
2nd Jun 20157:00 amRNSRe Agreement
6th May 20157:01 amRNSPlant Health Care Hires Jeff Tweedy
30th Apr 20153:02 pmRNSTotal Voting Rights
22nd Apr 20153:05 pmRNSTR1: Notificiation of Major Interest in Shares
17th Apr 20157:00 amRNSDIRECTORS' DEALING
15th Apr 20157:00 amRNSAnnual Report 2014 and Notice of AGM
8th Apr 20157:00 amRNSRe Agreement
30th Mar 20157:00 amRNSAnnual Financial Report
27th Mar 20157:00 amRNSDirectorate Change
5th Mar 201512:30 pmRNSPlant Health Care signs Distribution Agreement
20th Feb 20155:48 pmRNSBlocklisting Interim Review
17th Feb 20154:03 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSBoard changes and trading update
15th Dec 20141:51 pmRNSTR-1: Notification of Major Interest in Shares
5th Dec 20147:00 amRNSPHC Signs Agreement With Arysta LifeScience
19th Nov 20147:00 amRNSPlant Health Care Hires LHA
11th Nov 20144:05 pmRNSHolding(s) in Company
30th Oct 20147:00 amRNSPHC & Sipcam Enter Agreement
27th Oct 20147:00 amRNS3G Peptide Technology Platform shows major promise
23rd Oct 20144:29 pmRNSHolding(s) in Company
6th Oct 201411:25 amRNSDirector/PDMR Shareholding
2nd Oct 20147:00 amRNSDirector/PDMR Shareholding
15th Sep 20147:00 amRNSHalf Yearly Report
19th Aug 201410:28 amRNSAIM Blocklisting Return
12th Aug 20143:10 pmRNSTR-1 Notification of Major Interest in Shares
22nd Jul 20144:10 pmRNSTR-1 Notification of Major Interest in Shares
30th Jun 20149:18 amRNSTotal Voting Rights
5th Jun 201412:45 pmRNSTR-1 Notification of Major Interest in Shares
22nd May 20147:00 amRNSDelisting of shares from the CISX
8th May 20141:30 pmRNSAGM Voting Results
15th Apr 201411:30 amRNSDirector/PDMR Shareholding
15th Apr 20147:00 amRNSDirector/PDMR Shareholding
9th Apr 20142:15 pmRNSDirector's Dealing - Grant of Share Options
9th Apr 20142:00 pmRNSTR-1 Notification of Major Interest in Shares
7th Apr 20145:15 pmRNSPublication of Annual Report 2013 & Notice of AGM
31st Mar 20143:45 pmRNSTotal Voting Rights
24th Mar 20147:00 amRNSPreliminary Results
3rd Mar 20144:35 pmRNSPrice Monitoring Extension
28th Feb 20141:00 pmRNSTotal Voting Rights
19th Feb 201412:15 pmRNSBlocklisting Interim Review
17th Feb 20149:45 amRNSTR-1 Notification of Major Interest in Shares
6th Feb 20144:40 pmRNSSecond Price Monitoring Extn
6th Feb 20144:35 pmRNSPrice Monitoring Extension
31st Jan 20143:00 pmRNSTotal Voting Rights
15th Jan 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.